The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort

Cancer Causes and Control

Volumn 25, Issue 8, 2014, Pages 1029-1035

  Gaines, Alexis R ^a   Turner, Elizabeth L ^a   Moorman, Patricia G ^a,b   Freedland, Stephen J ^a,b,e   Keto, Christopher J ^d   McPhail, Megan E ^a,e   Grant, Delores J ^f   Vidal, Adriana C ^a,e   Hoyo, Cathrine ^a,b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c DUKE UNIVERSITY   (United States)

^d AKRON GENERAL MEDICAL CENTER   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

^f NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

Equal access; Initial biopsy; Prostate cancer; Race; Risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; BODY MASS; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; RETROSPECTIVE STUDY; ETHNOLOGY; HEALTH CARE DELIVERY; NEEDLE BIOPSY; PATHOLOGY; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; VETERAN;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BIOPSY, NEEDLE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; VETERANS;

EID: 84904572810     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0402-6     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11-30. doi:10.3322/caac.21166
2. Brawley OW, Knopf K, Thompson I (1998) The epidemiology of prostate cancer part II: the risk factors. Semin Urol Oncol 16(4):193-201 (Pubitemid 28553365)
3. Freedland SJ, Isaacs WB (2005) Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate 62(3):243-252. doi:10.1002/pros.20052 (Pubitemid 40129062)
4. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hayes RB, Hunter DJ, Chanock SJ (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40(3):310-315. doi:10.1038/ng.91 (Pubitemid 351311773)
5. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294(4):433-439 (Pubitemid 41124175)
6. Johnstone PA, Kane CJ, Sun L, Wu H, Moul JW, McLeod DG, Martin DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley J, Baldwin D, Soderdahl D, Do J, Amling CL (2002) Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the department of defense center for prostate disease research. Radiology 225(2):420-426 (Pubitemid 35239242)
7. Fowler JE Jr, Terrell F (1996) Survival in blacks and whites after treatment for localized prostate cancer. J Urol 156(1):133-136
8. Roach M III, Lu J, Pilepich MV, Asbell SO, Mohiuddin M, Grignon D (2003) Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials. J Urol 169(1):245-250 (Pubitemid 35461598)
9. Powell IJ, Schwartz K, Hussain M (1995) Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology 46(6):825-830. doi:10.1016/S0090-4295(99)80352-5
10. Hamilton RJ, Aronson WJ, Presti JC Jr, Terris MK, Kane CJ, Amling CL, Freedland SJ (2007) Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer 110(10):2202-2209 (Pubitemid 350100741)
11. Yanke BV, Carver BS, Bianco FJ Jr, Simoneaux WJ, Venable DD, Powell IJ, Eastham JA (2006) African-American race is a predictor of prostate cancer detection: incorporation into a prebiopsy nomogram. BJU Int 98(4):783-787. doi:10.1111/j.1464-410X.2006.06388.x (Pubitemid 44368025)
12. Kubricht WS, Kattan MW, Sartor O, Eastham JA (1999) Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer. Urology 53(3):553-556 (Pubitemid 29136201)
13. Tsivian M, Banez LL, Keto CJ, Abern MR, Qi P, Gerber L, Moul JW, Polascik TJ (2012) African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis. doi:10.1038/pcan.2012.39
14. Polednak AP (2002) Black-white differences in tumor grade (aggressiveness) at diagnosis of prostate cancer, 1992-1998. Ethn Dis 12(4):536-540
15. US Department of Veterans Affairs (2013) About the Durham Veterans Affairs Medical Center. US Department of Veterans Affairs, Washington, DC
16. US Department of Veterans Affairs (2012) Health benefits: veteran eligibility. US Department of Veterans Affairs, Washington, DC
17. US Census Bureau (2011) American Community Survey, public use microdata sample (PUMS). US Department of Commerce, Washington, DC
18. Department of Defense (2011) Population representation in the military services fiscal year 2011 report. Washington, DC
19. Zullig LL, Jackson GL, Dorn RA, Provenzale DT, McNeil R, Thomas CM, Kelley MJ (2012) Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. Mil Med 177(6):693-701
20. Agha Z, Lofgren RP, VanRuiswyk JV, Layde PM (2000) Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med 160(21):3252-3257
21. Moreira DM, Anderson T, Gerber L, Thomas JA, Banez LL, McKeever MG, Hoyo C, Grant D, Jayachandran J, Freedland SJ (2011) The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Cancer Causes Control 22(7):977-983. doi:10.1007/s10552-011-9770-3
22. Pierorazio PM, Walsh PC, Partin AW, Epstein JI (2013) Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int 111(5):753-760. doi:10.1111/j.1464-410X.2012.11611.x
23. Howlader NNA, Krapcho M et al (2013) SEER cancer statistics review, 1975-2010. National Cancer Institute, Bethesda
24. Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N (2009) Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agents cancer 4(Suppl. 1):S2. doi:10.1186/1750-9378-4-S1-S2
25. Powell IJ (2007) Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 177(2):444-449. doi:10.1016/j.juro.2006.09.024
26. Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr (2006) Assessing prostate cancer risk: results from the prostate cancer prevention trial. J Natl Cancer Inst 98(8):529-534. doi:10.1093/jnci/djj131 (Pubitemid 43898816)
27. Gann PH, Fought A, Deaton R, Catalona WJ, Vonesh E (2010) Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach. J Clin Oncol 28(10):1714-1720. doi:10.1200/JCO.2008.20. 3422
28. Carver BS, Bozeman CB, Simoneaux WJ, Venable DD, Kattan MW, Eastham JA (2004) Race is not a predictor of prostate cancer detection on repeat prostate biopsy. J Urol 172(5 Pt 1):1853-1855 (Pubitemid 39363072)
29. Bennett CL, Ferreira MR, Davis TC, Kaplan J, Weinberger M, Kuzel T, Seday MA, Sartor O (1998) Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol 16(9):3101-3104 (Pubitemid 28417432)
30. US Preventive Services Task Force (2012) Screening for prostate cancer: final recommendation statement. AHRQ Publication No. 12-05160-EF-2. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/ prostatefinalrs.htm. (Accessed June 2013)
31. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL (2013) Early detection of prostate cancer: AUA guideline. J Urol 190(2):419-426. doi: 10.1016/j.juro.2013.04.119
32. Carpenter WR, Beskow LM, Blocker DE, Forlenza MJ, Kim AE, Pevzner ES, Rose JM, Tran AN, Webber KH, Knight K, O'Malley MS (2008) Towards a more comprehensive understanding of cancer burden in North Carolina: priorities for intervention. N C Med J 69(4):275-282
33. Porterfield D, Knight K (2006) Running the numbers: a periodic feature to inform North Carolina healthcare professionals about current topics in health statistics. N C Med J 67(3):235-236
34. Nixon RG, Meyer GE, Brawer MK (1999) Differences in prostate size between patients from university and Veterans Affairs Medical Center populations. Prostate 38(2):144-150 (Pubitemid 29052953)
35. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl.):IV-3-IV-18. doi:10.1097/01.MLR.0000020942.47004.03
36. Boyko EJ, Koepsell TD, Gaziano JM, Horner RD, Feussner JR (2000) US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol 151(3):307-314 (Pubitemid 30463636)
37. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W (2006) Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 106(6):1276-1285. doi:10.1002/cncr.21732 (Pubitemid 43363904)
38. Saha S, Freeman M, Toure J, Tippens KM, Weeks C, Ibrahim S (2008) Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med 23(5):654-671. doi:10.1007/s11606-008-0521-4
39. Hsing AW, Chokkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388-1413 (Pubitemid 43253429)